SCHEMBL1665867

SCHEMBL1665867

COc1cnccc1-c1nc2cc(C(F)(F)F)cnc2s1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
METAP2 P50579 1/20 0.46
GPBAR1 Q8TDU6 6/20 0.43
AAK1 Q2M2I8 1/20 0.39
PDE2A O00408 3/20 0.39
PDE10A Q9Y233 3/20 0.39
DYRK1A Q13627 3/20 0.38
PDE6D O43924 2/20 0.37
PDE6A P16499 2/20 0.37
PDE6G P18545 2/20 0.37
PDE6B P35913 2/20 0.37
PDE6C P51160 2/20 0.37
PDE6H Q13956 2/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11895090 0.90 NPSR1 (0.37) CYP1A2METAP2GPBAR1AAK1PDE2A
SCHEMBL1665866 0.85 BUB1 (0.34) CYP1A2METAP2GPBAR1AAK1HPGD
SCHEMBL11894648 0.84 CYP1A2 (0.41) CYP1A2METAP2GPBAR1AAK1
SCHEMBL1665870 0.83 ILK (0.53) CYP1A2METAP2GPBAR1DYRK1A
SCHEMBL11895093 0.83 RAB9A (0.39) CYP1A2PDE2APDE10ADYRK1AHPGD
SCHEMBL11953200 0.83 DYRK1A (0.38) AAK1PDE10ADYRK1A
SCHEMBL11894951 0.82 ILK (0.34) CYP1A2METAP2GPBAR1PDE2APDE10A
SCHEMBL11895332 0.80 POLB (0.33) CYP1A2METAP2GPBAR1PDE2APDE10A
SCHEMBL11895033 0.79 DDR1 (0.41) DYRK1AHPGD
SCHEMBL11894806 0.78 ILK (0.32) GPBAR1PDE2APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486035-B1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST SUMITOMO CHEMICAL CO (JP) 2015-08-26 EP disclosed
EP-2486035-B1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST SUMITOMO CHEMICAL CO (JP) 2015-08-26 EP disclosed
US-8742112-B2 Heterocyclic compound and its use for control of an arthropod pest SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-06-03 US disclosed
US-8742112-B2 Heterocyclic compound and its use for control of an arthropod pest SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-06-03 US disclosed
US-20120196891-A1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-02 US disclosed
US-20120196891-A1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-02 US disclosed
WO-2011043404-A1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-14 WO disclosed
WO-2011043404-A1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196891-A1 HETEROCYCLIC COMPOUND AND ITS USE FOR CONTROL OF AN ARTHROPOD PEST HAAO, DDT, ACHE CYP1A2 7/4885METAP2 3749/4885GPBAR1 2783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.